HOLOGIC INC (HO1.DE) Stock Price & Overview
FRA:HO1 • US4364401012
Current stock price
The current stock price of HO1.DE is 69.09 EUR. Today HO1.DE is up by 0.98%. In the past month the price increased by 1.66%. In the past year, price increased by 19.12%.
HO1.DE Key Statistics
- Market Cap
- 17.249B
- P/E
- 10.12
- Fwd P/E
- 19.41
- EPS (TTM)
- 6.83
- Dividend Yield
- N/A
HO1.DE Stock Performance
HO1.DE Stock Chart
HO1.DE Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to HO1.DE. When comparing the yearly performance of all stocks, HO1.DE is one of the better performing stocks in the market, outperforming 90.65% of all stocks.
HO1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to HO1.DE. HO1.DE gets an excellent profitability rating and is at the same time showing great financial health properties.
HO1.DE Earnings
HO1.DE Forecast & Estimates
23 analysts have analysed HO1.DE and the average price target is 79.63 EUR. This implies a price increase of 15.25% is expected in the next year compared to the current price of 69.09.
For the next year, analysts expect an EPS growth of -29.23% and a revenue growth -10.55% for HO1.DE
HO1.DE Groups
Sector & Classification
HO1.DE Financial Highlights
Over the last trailing twelve months HO1.DE reported a non-GAAP Earnings per Share(EPS) of 6.83. The EPS decreased by -23.16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 28.93% | ||
| ROA | 16.16% | ||
| ROE | 30.25% | ||
| Debt/Equity | 0.57 |
HO1.DE Ownership
HO1.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 14.05 | 96.098B | ||
| 1MDT | MEDTRONIC PLC | 14.04 | 96.021B | ||
| SHL | SIEMENS HEALTHINEERS AG | 13.79 | 40.597B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 15.42 | 22.706B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 15.41 | 22.696B | ||
| BIM | BIOMERIEUX | 19.21 | 11.084B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 18.02 | 3.459B | ||
| DIA | DIASORIN SPA | 15.06 | 3.45B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 12.09 | 2.222B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.4 | 1.696B | ||
| DRW8 | DRAEGERWERK AG | 8.95 | 1.332B | ||
| ELN | EL.EN. SPA | 16.09 | 1.005B | ||
| EUZ | ECKERT & ZIEGLER SE | 17.33 | 925.486M |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About HO1.DE
Company Profile
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. The company is headquartered in Marlborough, Massachusetts and currently employs 6,705 full-time employees. The firm operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a range of diagnostics products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a portfolio of solutions for breast cancer care for radiology, pathology and surgery. The GYN Surgical segment offers a range of products, including its NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System as well as its Fluent Fluid Management system. The Skeletal Health segment offers products such as the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm.
Company Info
IPO: 1990-03-01
HOLOGIC INC
250 Campus Drive
Marlborough MASSACHUSETTS US
Employees: 6705
Phone: 17819997300.0
HOLOGIC INC / HO1.DE FAQ
Can you describe the business of HOLOGIC INC?
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. The company is headquartered in Marlborough, Massachusetts and currently employs 6,705 full-time employees. The firm operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a range of diagnostics products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a portfolio of solutions for breast cancer care for radiology, pathology and surgery. The GYN Surgical segment offers a range of products, including its NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System as well as its Fluent Fluid Management system. The Skeletal Health segment offers products such as the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm.
What is the stock price of HOLOGIC INC today?
The current stock price of HO1.DE is 69.09 EUR. The price increased by 0.98% in the last trading session.
Does HO1 stock pay dividends?
HO1.DE does not pay a dividend.
How is the ChartMill rating for HOLOGIC INC?
HO1.DE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Is HOLOGIC INC (HO1.DE) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on HO1.DE.
Can you provide the growth outlook for HOLOGIC INC?
The Revenue of HOLOGIC INC (HO1.DE) is expected to decline by -10.55% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.